Discovery of enantioselectivity of urea inhibitors of soluble epoxide hydrolase-Reference-Cited by-同舟云学术

Discovery of enantioselectivity of urea inhibitors of soluble epoxide hydrolase

Published:2016-07 Issue: Volume:117 Page:113-124
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Manickam Manoj,Pillaiyar Thanigaimalai,Boggu PullaReddy,Venkateswararao Eeda,Jalani Hitesh B.,Kim Nam-Doo,Lee Seul Ki,Jeon Jang Su,Kim Sang Kyum,Jung Sang-Hun

Funder

Ministry of Education, Science and Technology

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference39 articles.

1. Arachidonic acid cytochrome P450 epoxygenase pathway;Spector;J. Lipid Res.,2009

2. Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase;Moghaddam;Nat. Med.,1997

3. A new class of lipid mediators: cytochrome P450 arachidonate metabolites,;Carroll;Thorax,2000

4. Cytochrome P450 and arachidonic acid bioactivation: molecular and functional properties on the arachidonate monooxygenase;Capdevila;J. Lipid Res.,2000

5. Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids;Yu;Circ. Res.,2000

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and Properties of N,N′-Disubstituted Ureas and Their Isosteric Analogs Containing Polycyclic Fragments: XIX. exo-Isomers of N-(1,7,7-Trimethylbicyclo[2.2.1]heptan-2-yl)-N′-R-ureas and -thioureas;Russian Journal of Organic Chemistry;2024-03

2. A Comprehensive Review of Soluble Epoxide Hyådrolase Inhibitors Evaluating their Structure-Activity Relationship;Mini-Reviews in Medicinal Chemistry;2023-01

3. Ureas derived from camphor and fenchone reveal enantiomeric preference of human soluble epoxide hydrolase;RESULTS CHEM;2022

4. Ureas derived from camphor and fenchone reveal enantiomeric preference of human soluble epoxide hydrolase;Results in Chemistry;2022-01

5. Activating endogenous resolution pathways by soluble epoxide hydrolase inhibitors for the management of COVID‐19;Archiv der Pharmazie;2021-11-21